XTL Biopharmaceuticals to acquire Psyga Bio for psychedelic platform Apr 29, 2026 08:59AM
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologi Apr 29, 2026 08:58AM
XTL Biopharmaceuticals acquires 85% stake in NeuroNOS for autism therapeutics Jan 13, 2026 09:28AM
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership Jan 13, 2026 09:28AM
XTL Biopharmaceuticals acquires 85% of Beyond Air's NeuroNOS subsidiary Jan 13, 2026 07:31AM


Jan 13, 2026 07:30AM XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership